Disposable Solutions for Biomanufacturing Conference

We bring Disposable Solutions for Biomanufacturing Summit to Europe which will be held on 19th-20th February, 2013 in Brussels, Belgium. The event focuses entirely on the application of single-use technology within manufacturing with studies on extractables and leachables, supply chain reliability, objective cost analysis and innovative case studies.

[inlinead]

What last year attendees thought?

• "Provided a vibrant networking platform, as well as informative content on the latest technological and strategic developments across the single use industry" - Arnaud Schmutz, General Manager, Sourcin
• "Good mix of topics. Very good range of relevant subjects with good speaker knowledge" - MSD
• "Excellent mix of speakers & topics. Very valuable" - Pfizer
• "Very valuable" - MSD Biologics UK

Top Reasons to attend the event :

• Latest technological innovations and demonstrations in the latest upstream & downstream product launches all under one roof
• GMP compliance, European & US Regulatory updates, best practice guidelines and analysis on Extractables and leachables
• Insights on Supply chain reliability, Single-use equipment validation and quality control
• New facility design and existing conversion in Bioprocess design and optimisation
• New case studies from leading innovators and CMOs + Online preconference learning with a series of webinar

>> Download the complete agenda
 

Expert Speakers Include :

• Vincent Thibon, Senior Analytical Scientist, GlaxoSmithKline
• Arnaud Schmutz, CEO & General Manager, Sourcin
• Doug Ball, Research Fellow, Pfizer
• Tony Hitchcock, Head of Manufacturing Technologies, Cobra Biomanufacturing

>> Get the complete speakers list here

Disposable Solutions for Biomanufacturing - Special Report 2013

The last 10 years has seen a surge in the use of single-use and disposable systems for the production of biopharmaceuticals, initially in early stage products, but increasingly in commercial products. Exclusively revealing the results of a Pharma IQ  industry-wide survey, almost a quarter of respondents say their number one goal for 2013 is to move single use systems from development into commercial use, and 45% cited cost savings as the biggest factor for doing so.This Special Report is part of our Pharma Industry Series.

>> Download the complete Whitepaper!